CHRISTINA COTTON: Open Payments
NPI 1629715768 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 41 payments from 15 companies in 2025. Trend: 2023 $1,089 · 2024 $1,663 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $173 |
| ABBVIE INC. | 12 | $172 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Lundbeck LLC | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, SPRAVATO, HETLIOZ, Dyanavel XR, COBENFY.
Industry payments across KY — which companies pay providers there.
